PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsNovarel
Novarel
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
335 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfertilityD007246HP_0000789—715245469164
Polycystic ovary syndromeD011085EFO_0000660E28.255841230
Female infertilityD007247EFO_0008560N9734451730
SyndromeD013577——22551528
Fertilization in vitroD005307——1237921
HypogonadismD007006HP_0000044E23.01246619
Ovulation inductionD010062——14—1814
Kallmann syndromeD017436Orphanet_478E23.0——1539
Assisted reproductive techniquesD027724——1—2148
Ovarian hyperstimulation syndromeD016471————1438
Show 11 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Primary ovarian insufficiencyD016649EFO_0004266E28.3132—26
Pregnancy rateD018873————1—23
RecurrenceD012008———21—13
AnovulationD000858———11—13
PregnancyD011247EFO_0002950Z33.1——1—23
Pituitary diseasesD010900—E23.7—11—13
Pre-eclampsiaD011225EFO_0000668O14——1—12
EclampsiaD004461HP_0100601O15——1—12
Klinefelter syndromeD007713EFO_1001006Q98.0——1—12
Spontaneous abortionD000022EFO_1001255O00.1—11——1
Show 4 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Premature menopauseD008594HP_0008209E28.3111——23
Breast neoplasmsD001943EFO_0003869C50—1——23
Graft vs host diseaseD006086—D89.8132———3
Ischemic strokeD000083242———3———3
StrokeD020521EFO_0000712I63.9—3———3
LeiomyomaD007889HP_0000131D2511——12
AzoospermiaD053713EFO_0000279N46.0—1——12
Wounds and injuriesD014947—T14.8—1——12
Healthy volunteers/patients———21———2
InfectionsD007239EFO_0000544—11———1
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperandrogenismD017588——2———13
Retinal diseasesD012164HP_0000479H35.91————1
Hemophilia aD006467EFO_0007267D661————1
AtrophyD001284——1————1
GynatresiaD006175EFO_1001335—1————1
Postoperative painD010149—G89.181————1
Oocyte retrievalD054315——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Premature birthD047928EFO_0003917O60————33
Gestational trophoblastic diseaseD031901—O01.9————22
Down syndromeD004314EFO_0001064Q90————22
Premature obstetric laborD007752—O60————22
EunuchismD005058EFO_0007266E29.1————22
Male infertilityD007248EFO_0004248N46————22
Trophoblastic neoplasmsD014328——————22
MicrobiotaD064307——————22
Ovarian pregnancyD065172—O00.2————11
OogenesisD009866——————11
Show 39 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification—
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use